Mounjaro (Tirzepatide) Administration and Efficacy
Introduction to Mounjaro
- Taking Mounjaro at bedtime may help patients sleep through initial nausea, similar to other medications with gastrointestinal side effects, as suggested by the American Journal of Respiratory and Critical Care Medicine 1
Dosing and Administration
- No dose adjustment is required for patients with renal impairment, unlike some other GLP-1 receptor agonists that require adjustments with decreased kidney function, according to the Mayo Clinic Proceedings and clinical recommendations 2, 3
- The recommended initiation dose is 2.5 mg once weekly for 4 weeks, then increase to 5 mg once weekly after 4 weeks, as per clinical guidelines 3
- If additional glycemic control is needed, the dosage can be increased in 2.5 mg increments after at least 4 weeks on the current dose, to minimize gastrointestinal side effects, although the strength of evidence is not specified 3
Efficacy and Mechanism of Action
- Tirzepatide is a dual incretin agonist that targets both GLP-1 and GIP receptors, making it effective for glycemic control in type 2 diabetes, weight reduction, and potential delay in progression from prediabetes to type 2 diabetes, as stated by the American Diabetes Association guidelines and clinical data 1, 4
- For once-weekly GLP-1 receptor agonists like tirzepatide, the specific time of day is less important than maintaining consistency in the weekly schedule, according to the American Diabetes Association guidelines 4
- The following table summarizes the importance of consistency in administration:
| Medication | Administration Schedule |
|---|---|
| Once-weekly GLP-1 receptor agonists (e.g., tirzepatide) | No change of time needed, emphasize consistency |
Management of Side Effects
- Gastrointestinal side effects are most common, including nausea (31%), diarrhea (23%), and vomiting (12%), according to clinical data 3
- To minimize these effects, reduce meal size, limit alcohol and carbonated drinks, and avoid high-fat diets, as suggested by clinical guidelines 3
- Antiemetics like ondansetron and loperamide may be used to manage nausea and diarrhea if needed, based on clinical recommendations 3
- Consider stopping tirzepatide at least one week before elective procedures to minimize the risk of aspiration due to delayed gastric emptying, as advised by clinical guidelines 3